Professor Roderick Skinner
Dr Mark Velangi
| "We Can Work It out": The Development of a Consensus Approach to Decision Making in Allogeneic Stem Cell Transplantation in the UK | 2015 |
|
Dr Mark Velangi
Professor Roderick Skinner
Dr Sujith Samarasinghe
| Similar Outcome of Upfront Unrelated and Matched Sibling Donor Hematopoietic Stem Cell Transplantation in Idiopathic Anlastic Anaemia of Childhood and Adolescence: A Cohort Controlled Study on Behalf of the UK Paediatric BMT WP, of the PD WP and of the SAA WP of the EBMT | 2014 |
|
Dr Mark Velangi
Professor Roderick Skinner
Dr Sujith Samarasinghe
| Upfront matched and mismatched unrelated transplantation in paediatric aplastic anaemia: a United Kingdom multicentre retrospective experience | 2014 |
|
Professor Roderick Skinner
Dr Mark Velangi
Dr Nicholas Bown
| Donor lymphocyte infusions for post-transplant relapse of refractory anemia with excess blasts and monosomy 7 | 2008 |
|
Dr Tina Biss
Dr Mark Velangi
Dr John Hanley
| Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature | 2006 |
|
Dr Mark Velangi
Dr Michael Reid
Professor Roderick Skinner
| Hybrid chemotherapy in two children with acute leukemia of ambiguous lineage | 2006 |
|
Dr Mark Velangi
Elizabeth Matheson
Dr Andrew Hall
Professor Julie Irving
| Detecting mismatch repair defects in myeloma | 2005 |
|
Dr Mark Velangi
Professor Graham Jackson
| Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey | 2005 |
|
Dr Mark Velangi
| Reply to Saravanamuttu et al: Uptake of high dose therapy and peripheral blood stem cell transplantation in myeloma patients < 65 years - the role of the myeloma multi-disciplinary team | 2005 |
|
Professor Graham Jackson
Dr Mark Velangi
| Only a minority of age eligible patients with myeloma undergo treatment with autologous transplantation. A population based study of the contributory factors. A combined survey on behalf of The Northern Ireland Regional Haematology Group (NIRHG) and The Newcastle Regional Haematology Group (NRHG) | 2004 |
|
Professor Graham Jackson
Dr Mark Velangi
| Only a minority of myeloma patients aged under 65 years receive high-dose therapy with autologous transplantation | 2004 |
|
Dr Mark Velangi
Professor Graham Jackson
Dr Penelope Taylor
Dr Andrew Hall
Professor Julie Irving
et al. | DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma | 2003 |
|
Dr Mark Velangi
Dr Michael Reid
Dr Nicholas Bown
Professor Graham Jackson
Professor Stephen Proctor
et al. | Acute lymphoblastic leukaemia of the L3 subtype in adults in the Northern health region of England 1983-99 | 2002 |
|
